The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.
You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.
We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.
We are interested in where in or outside the cell the gene product carries out its function.
We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.
Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.
The requested identity is verified: CLRN1 is the human clarin 1 gene, also named USH3A, and UniProt P58418 is its protein product, clarin-1/Usher syndrome type-3 protein. The literature consistently describes the principal disease-relevant product as a 232-amino-acid, glycosylated, four-pass membrane protein in the clarin family. This agrees with the supplied Clarin annotations, IPR026748 and PF25807. No literature concerning a different, similarly named gene was used. (xu2020clarin‐1expressionin pages 1-5, geng2009ushersyndromeiiia pages 1-2, xu2020clarin‐1expressionin pages 10-14)
The best-supported primary function is not enzymatic catalysis or substrate transport. Clarin-1 is a specialized membrane scaffold/organizer. In cochlear hair cells it operates at two polarized compartments:
In adult human retina, the strongest endogenous-expression evidence places CLRN1 predominantly in Müller glia, but its precise retinal biochemical function remains unresolved. A structural/homeostatic role supporting photoreceptors is more defensible than a direct photoreceptor-autonomous mechanism. (xu2020clarin‐1expressionin pages 1-5, dulon2018clarin1genetransfer pages 13-14, dulon2018clarin1genetransfer pages 1-3)
The principal CLRN1 isoform comprises exons 1, 3, and 4 and encodes 232 amino acids; a shorter 172-aa isoform has also been detected. The main isoform is predicted to cross the membrane four times and possesses an N-linked glycosylation site at Asn48 in its first extracellular loop. Endogenous retinal protein migrated at approximately 26 kDa and shifted below 25 kDa after PNGase-F digestion, experimentally confirming glycosylation. All known USH3 mutations considered in the isoform study occurred in the principal 232-aa isoform. (xu2020clarin‐1expressionin pages 1-5, xu2020clarin‐1expressionin pages 10-14)
“Tetraspan-like” describes CLRN1's four-pass architecture and functional resemblance to membrane-organizing proteins; it should not be interpreted as proof that clarin-1 is a canonical tetraspanin. Its small extracellular and intracellular regions, including a candidate C-terminal PDZ-binding sequence, are compatible with assembly of membrane–cytoskeleton complexes. Heterologous-cell experiments found CLRN1 concentrated in membrane microdomains, recruiting proteins associated with adhesion, focal adhesions, and tight junctions and altering actin organization. These results provide a plausible unifying scaffold model, although overexpression in HEK cells does not establish that every interaction occurs endogenously in sensory cells. (dinculescu2021retinalgenetherapy pages 6-9)
Cochlear hair-cell stereocilia are actin-filled projections whose deflection gates the mechanotransduction apparatus. In Clrn1-null mice, tip links and stereociliary rank order remain detectable, but bundles lose their normal V-shaped organization, become fragmented, and lose some tallest-row stereocilia. Mechanotransduction is reduced rather than abolished. Thus, CLRN1 is required for bundle integrity and optimal transduction, but evidence does not identify clarin-1 itself as the transduction channel or an essential tip-link component. The transduction defect may be largely secondary to structural disorganization. (geng2012themechanosensorystructure pages 11-12)
The in-vivo phenotype is severe: Clrn1 expression occurs in auditory and vestibular hair cells and associated neurons during development; in one knockout series, 70% of mice lacked detectable auditory brainstem responses by postnatal day 21 and all were deaf by P30. Progressive vestibular dysfunction, early outer-hair-cell stereociliary abnormalities, and later hair-cell loss were also observed. (geng2009ushersyndromeiiia pages 1-2)
Accordingly, the most precise apical annotation is: plasma-membrane-associated organizer of the stereociliary actin architecture, necessary for hair-bundle morphogenesis/maintenance and efficient sensory mechanotransduction.
Clarin-1 also has a separable basolateral function. Conditional postnatal deletion can initially leave hair-bundle morphology and otoacoustic emissions normal while producing progressive auditory failure, showing that the phenotype is not exclusively an apical-bundle defect. Mutant inner hair cells retain ribbons but develop immature or abnormally small ribbons, fragmented synaptic F-actin, enlarged/dispersed CaV1.3 patches, impaired Ca²⁺-evoked exocytosis, broadened postsynaptic GluA2/3 AMPA-receptor territories, swollen or missing afferent endings, and defective auditory-neuron responses. These abnormalities arise around hearing onset, supporting a role in maturation and maintenance rather than initial synapse specification. (dulon2018clarin1genetransfer pages 7-10, dulon2018clarin1genetransfer pages 1-3, dulon2018clarin1genetransfer pages 14-17, dulon2018clarin1genetransfer pages 17-18)
The physiological effect is substantial. Exocytotic time constants increased from 25 ± 10 to 102 ± 50 ms with 1 mM EGTA and from 33 ± 18 to 205 ± 32 ms with 5 mM EGTA. This enhanced sensitivity to intracellular Ca²⁺ buffering indicates that CaV1.3 channels and release-ready vesicles become abnormally separated when clarin-1 is absent. (dulon2018clarin1genetransfer pages 7-10)
Biochemical experiments support a mechanistic complex:
The resulting model is that clarin-1 bridges a membrane calcium-channel complex to harmonin and cortical actin, keeping CaV1.3 channels tightly clustered near synaptic vesicles. The mouse genetic, imaging, electrophysiological, biochemical, and gene-rescue evidence makes this the strongest mechanistic annotation presently available, although direct demonstration of the complete endogenous complex in human cochlea is lacking. (dulon2018clarin1genetransfer pages 13-14, dulon2018clarin1genetransfer pages 1-3, dulon2018clarin1genetransfer pages 14-17)
Functionally relevant clarin-1 occurs at the plasma membrane of sensory hair cells, including the apical stereociliary bundle and the basolateral inner-hair-cell ribbon active zone. The two locations explain the combined bundle and synaptic phenotypes. Expression has also been reported in vestibular hair cells and associated auditory/vestibular neurons, but the most precise causal evidence concerns hair cells. (geng2009ushersyndromeiiia pages 1-2, dulon2018clarin1genetransfer pages 13-14)
Retinal localization was historically disputed because CLRN1 is scarce, available antibodies were inconsistent, and ectopic AAV expression can place protein in cell types that do not normally express it. RNAscope and single-cell RNA sequencing subsequently showed significant enrichment of CLRN1 transcripts in Müller glia rather than photoreceptors in adult human, macaque, and mouse retina. An endogenous HA-tagged mouse allele and deglycosylation-sensitive immunoblotting confirmed persistent retinal protein expression, although protein-level cellular immunolocalization remained technically difficult. (xu2020clarin‐1expressionin pages 1-5, xu2020clarin‐1expressionin pages 10-14, xu2020clarin‐1expressionin pages 22-30)
Therefore, Müller glia are the best-supported retinal site of action. The exact subcellular compartment and biochemical task remain unsettled. Current hypotheses emphasize Müller-glial actin architecture, adhesion, structural coupling to photoreceptors, and maintenance of retinal homeostasis. These are biologically coherent extensions of the membrane–actin scaffold model, not yet equivalent in evidentiary strength to the cochlear synapse mechanism. Conventional Clrn1-null mice also fail to reproduce human retinal degeneration, limiting mechanistic inference from that species. (xu2020clarin‐1expressionin pages 1-5, nonarath2025theush3acausative pages 2-4)
CLRN1 does not belong to a conventional metabolic pathway. Its relevant functional modules are:
This network explains why loss of a small membrane protein can affect both mechanical architecture and synaptic signaling without CLRN1 itself being a channel, enzyme, or transporter.
The recurrent p.Asn48Lys (N48K) variant eliminates the conserved N48 glycosylation site. Mutant protein is inefficiently processed, retained in the endoplasmic reticulum, and susceptible to degradation; only a fraction reaches the hair bundle. This is a loss-of-function mechanism based partly on insufficient surface delivery rather than complete absence of protein. (gopal2019unconventionalsecretorypathway pages 7-8, gopal2019unconventionalsecretorypathway pages 1-2)
In zebrafish, escaped CLRN1-N48K uses a GRASP55 cargo-dependent unconventional secretory pathway, bypassing conventional ER–Golgi trafficking. GRASP55 expression raised measured bundle fluorescence to 23.12 ± 1.56 versus about 5.9 pixels in controls and increased the bundle:soma ratio from approximately 0.19–0.21 to 0.63. (gopal2019unconventionalsecretorypathway pages 3-4)
Artemisinin, used experimentally to activate this pathway through ER-calcium/SERCA perturbation, produced strong bundle signal in 76% of bundles after 0.4 μM for four hours, versus under 5% untreated, and increased bundle fluorescence approximately fivefold. Repeated exposure restored zebrafish microphonic potentials toward wild-type values. This is compelling proof of mechanism in a fish model, not evidence of efficacy or long-term safety in patients. (gopal2019unconventionalsecretorypathway pages 4-5, gopal2019unconventionalsecretorypathway pages 7-8)
Biallelic pathogenic CLRN1 variants cause autosomal-recessive Usher syndrome type IIIA, typically involving progressive sensorineural hearing loss, rod–cone retinal degeneration, and variable vestibular dysfunction. The tempo varies considerably among genotypes and even relatives. A 2024 family study notes vestibular-test abnormalities in approximately 51% of tested USH3 patients. Reported proportions of USH attributable to USH3 vary greatly by ascertainment and founder population—from about 6% in one Spanish cohort to 20% in Birmingham and approximately 40% in Finnish/Ashkenazi Jewish cohorts—and should not be treated as general-population prevalence. (wang2024araretranscript pages 9-11, wang2024araretranscript pages 2-4)
Wang and colleagues reported a homozygous CLRN1 alteration in a Chinese family that has different predicted consequences depending on transcript: c.474T>A, p.Cys158Ter in NM_001256819.2, versus c.302T>A, p.Val101Asp in NM_174878.3. Expression experiments found loss of protein for p.Cys158Ter but not p.Val101Asp. The variant cosegregated with disease, was absent from major population/clinical databases, and was classified pathogenic using PS3 + PM2 + PP4 + PP1. This demonstrates that isoform-aware annotation and experimental validation are essential for CLRN1 diagnosis. Published September 2024: https://doi.org/10.1186/s13023-024-03348-x. (wang2024araretranscript pages 9-11, wang2024araretranscript pages 2-4, wang2024araretranscript pages 11-12)
A separate 2024 pilot analysis of patient-derived transformed lymphocyte lines reported 92 differentially expressed miRNAs across Usher samples, including five categorized as USH3-specific, and downregulation of members of the miR-183 family. Because the CLRN1 subgroup was extremely small and the tissue was not cochlea or retina, these results are exploratory biomarker observations, not a demonstrated CLRN1 pathway or clinically validated test. Published September 2024: https://doi.org/10.3390/ijms25189993.
The immediate real-world uses of CLRN1 knowledge are molecular diagnosis, recessive-risk counseling, genotype-informed surveillance, and anticipatory rehabilitation. Hearing aids and cochlear implantation can address progressive severe hearing loss; retinal monitoring, low-vision services, orientation/mobility support, and management of vestibular impairment remain supportive. There is no evidence in the retrieved literature of an approved treatment that corrects clarin-1 deficiency or prevents CLRN1-associated retinal degeneration.
AAV2/8-Clrn1 delivery through the round window at P1–P3 transduced approximately 90% of mouse inner hair cells but only 20% of outer hair cells. In a conditional model, treatment restored active-zone organization and exocytosis and produced near-normal early ABR thresholds—about 20 dB at 10 kHz and 38 dB at 20 kHz at P22–P24. Benefit persisted at P60 but declined by P120. Rescue was much poorer in constitutive knockouts with established bundle malformation, indicating a narrow requirement for treatment before irreversible structural damage. Published July 2018: https://doi.org/10.1172/JCI94351. (dulon2018clarin1genetransfer pages 13-14, dulon2018clarin1genetransfer pages 10-13)
Retinal translation requires particular caution. Ubiquitous, high-dose subretinal AAV expression caused significant ERG loss in mice, demonstrating that excessive or ectopic CLRN1 can be harmful. A successful retinal vector will probably require Müller-glia-appropriate targeting, regulated expression, and careful dose selection. Published February 2016: https://doi.org/10.1371/journal.pone.0148874. (dinculescu2016aavmediatedclarin1expression pages 1-2)
Artemisinin/GRASP55 activation and compounds intended to stabilize N48K surface expression, including BF844, represent variant-specific proteostasis strategies. The strongest retrieved efficacy data remain preclinical, particularly zebrafish mechanotransduction rescue. They should not be described as established patient therapies. A registry search did not identify a relevant completed CLRN1-targeted efficacy trial; therefore, the field remains at preclinical or early translational development rather than demonstrated human disease modification.
The table below separates robust experimental conclusions from model-dependent inference.
| Annotation question | Best-supported conclusion | Evidence/model and quantitative detail | Confidence / limitation |
|---|---|---|---|
| Identity and topology | The target is human CLRN1/USH3A, encoding clarin-1 (UniProt P58418), not a similarly named gene. The principal disease-relevant isoform is a 232-aa, four-pass tetraspan-like membrane protein in the clarin family, matching the supplied Clarin domain annotations IPR026748/PF25807. Its first extracellular loop contains the N48 N-linked glycosylation site. | Endogenous retinal clarin-1 migrated at approximately 26 kDa and shifted below 25 kDa after PNGase F treatment. Isoform analysis identified the 232-aa principal isoform and a 172-aa alternative isoform; known USH3 mutations were reported in the principal isoform. (geng2009ushersyndromeiiia pages 1-2, xu2020clarin‐1expressionin pages 10-14) | High for identity, size, topology, and glycosylation. Family/domain labels derive chiefly from curated sequence annotation; “tetraspan-like” describes architecture and does not make CLRN1 a canonical tetraspanin. |
| Cochlear apical function | At the apical pole of auditory hair cells, clarin-1 is best classified as a membrane-associated organizer required for morphogenesis and maintenance of the F-actin-rich stereociliary hair bundle. It supports efficient mechanotransduction but is not established as the transduction channel or a transported-substrate carrier. | Clrn1-null mouse hair cells retained tip links and graded stereociliary rows but developed fragmented/disorganized bundles and reduced—not abolished—mechanotransduction. In an earlier knockout study, 70% of mice lacked detectable ABRs by postnatal day 21 and all were deaf by P30. (geng2012themechanosensorystructure pages 11-12, geng2009ushersyndromeiiia pages 1-2) | High for bundle maintenance and functional necessity; moderate for the precise molecular mechanism. Reduced mechanotransduction may be secondary to structural bundle disruption. |
| Basolateral inner-hair-cell function | At the basolateral inner-hair-cell ribbon synapse, clarin-1 acts as an active-zone membrane scaffold/organizer linking the cortical F-actin network to the CaV1.3–CaVβ2 calcium-channel complex and harmonin, thereby promoting tight channel clustering, efficient Ca²⁺–vesicle coupling, exocytosis, and aligned postsynaptic signaling. | Loss of Clrn1 enlarged/disorganized CaV1.3 patches, fragmented synaptic F-actin, slowed exocytosis, broadened GluA2/3 AMPA-receptor territories, and damaged afferent endings. Exocytotic time constants increased from 25 ± 10 to 102 ± 50 ms with 1 mM EGTA and from 33 ± 18 to 205 ± 32 ms with 5 mM EGTA. GST pull-down/co-immunoprecipitation supported binding of clarin-1 termini to CaVβ2/CACNB2, CaV1.3-complex association through CaVβ2, and C-terminal binding to harmonin-b. (dulon2018clarin1genetransfer pages 7-10, dulon2018clarin1genetransfer pages 13-14, dulon2018clarin1genetransfer pages 1-3, dulon2018clarin1genetransfer pages 14-17) | High for synaptic organization in mouse IHCs and biochemical association; moderate for a direct endogenous human complex. Clarins are not proven enzymes, ion channels, or transporters. |
| Broader membrane mechanism | Clarin-1 likely creates specialized membrane microdomains that recruit adhesion/junction proteins and couple membrane organization to actin architecture. | Overexpressed HA-tagged CLRN1 concentrated in defined HEK-cell plasma-membrane regions, recruited proteins associated with cell adhesion, focal adhesions, and tight junctions, and altered actin organization. (dinculescu2021retinalgenetherapy pages 6-9) | Moderate-to-low for physiological tissues because much of this evidence comes from heterologous overexpression; it provides a plausible unifying mechanism rather than proof of an endogenous signaling pathway. |
| Retinal cell type and function | In adult human and mouse retina, the strongest endogenous expression evidence places CLRN1 predominantly in Müller glia, not photoreceptors. Its precise retinal biochemical function remains unresolved; current evidence favors a glial structural/homeostatic role that supports photoreceptors non-cell-autonomously. | RNAscope and single-cell RNA-seq localized CLRN1/Clrn1 transcripts to Müller glia in adult human, macaque, and mouse retina. Endogenous tagged mouse protein and immunoblotting supported persistent, glycosylated retinal expression despite low transcript abundance. (xu2020clarin‐1expressionin pages 1-5, xu2020clarin‐1expressionin pages 10-14, xu2020clarin‐1expressionin pages 22-30) | High for Müller-glial transcript enrichment; moderate for protein-level cellular localization and low-to-moderate for exact retinal mechanism. AAV overexpression in photoreceptors does not establish endogenous localization, and conventional mouse knockouts lack human-like retinal degeneration. |
| N48K pathogenic mechanism and trafficking rescue | The founder variant p.Asn48Lys (N48K) removes the conserved glycosylation site, causing defective processing, ER retention/degradation, and reduced delivery to hair bundles. A fraction can bypass the conventional ER–Golgi route through a GRASP55-dependent unconventional secretory pathway; artemisinin can enhance this route in zebrafish. | GRASP55 expression increased bundle fluorescence to 23.12 ± 1.56 versus approximately 5.9 pixels in controls and increased the bundle:soma ratio to 0.63 versus 0.193–0.213. After 0.4 μM artemisinin for 4 h, 76% of bundles showed strong mutant protein signal versus under 5% untreated, with approximately fivefold greater fluorescence; repeated treatment restored microphonic potentials toward wild type. (gopal2019unconventionalsecretorypathway pages 4-5, gopal2019unconventionalsecretorypathway pages 7-8, gopal2019unconventionalsecretorypathway pages 1-2, gopal2019unconventionalsecretorypathway pages 3-4) | High for ER retention and zebrafish trafficking/functional rescue; low for human therapeutic efficacy. Artemisinin’s proposed CLRN1 use remains preclinical, and chronic pathway activation could have off-target effects. |
| AAV gene replacement | Early postnatal AAV2/8-Clrn1 delivery can prevent or reverse synaptic defects and preserve hearing in mouse models, particularly when treatment precedes irreversible hair-bundle pathology. | Round-window delivery at P1–P3 transduced approximately 90% of IHCs but only 20% of OHCs. In conditional mutants, ABR thresholds at P22–P24 approached 20 dB at 10 kHz and 38 dB at 20 kHz; benefit persisted at P60 but deteriorated by P120. Rescue was limited in constitutive knockouts with pre-existing bundle malformation. (dulon2018clarin1genetransfer pages 13-14, dulon2018clarin1genetransfer pages 10-13) | High as mouse proof of concept; low-to-moderate for translation. Timing, OHC transduction, durability, delivery, and dosage remain barriers. Retinal overexpression can itself reduce ERG function, emphasizing cell-specific promoters and dose control. (dinculescu2016aavmediatedclarin1expression pages 1-2) |
| 2024 transcript-specific variant development | A 2024 study showed that transcript choice can change the interpreted molecular consequence of a CLRN1 variant, strengthening the need for isoform-aware diagnostics and functional validation. | In a Chinese family, the same genomic locus was described as c.474T>A (p.Cys158Ter; NM_001256819.2) or c.302T>A (p.Val101Asp; NM_174878.3). Expression experiments found loss of protein for p.Cys158Ter but not p.Val101Asp; the variant cosegregated with disease, was absent from major databases, and was classified pathogenic using PS3 + PM2 + PP4 + PP1. (wang2024araretranscript pages 9-11, wang2024araretranscript pages 2-4, wang2024araretranscript pages 11-12) | Moderate: compelling family segregation and functional evidence, but based on one pedigree and heterologous/lymphoblastoid assays. The result chiefly informs variant annotation rather than changing CLRN1’s core molecular function. |
Table: Evidence-graded summary of human clarin-1 identity, cellular roles, localization, pathogenic trafficking defects, and translational findings. Quantitative details distinguish well-supported functions from model-dependent hypotheses.
Overall, CLRN1 should be functionally annotated as a glycosylated four-pass membrane scaffold that couples specialized membrane domains to actin-based architecture and presynaptic Ca²⁺-release machinery. This conclusion is strong in cochlear hair cells, especially at the inner-hair-cell ribbon synapse. In the retina, Müller glia are the most credible site of action, but the downstream function remains an active research question.
References
(xu2020clarin‐1expressionin pages 1-5): Lei Xu, Susan N Bolch, Clayton P Santiago, Frank M Dyka, Omar Akil, Ekaterina S Lobanova, Yuchen Wang, Kirill A Martemyanov, William W Hauswirth, W Clay Smith, James T Handa, Seth Blackshaw, John D Ash, and Astra Dinculescu. Clarin‐1 expression in adult mouse and human retina highlights a role of müller glia in usher syndrome. The Journal of Pathology, 250:195-204, Dec 2020. URL: https://doi.org/10.1002/path.5360, doi:10.1002/path.5360. This article has 35 citations.
(geng2009ushersyndromeiiia pages 1-2): Ruishuang Geng, S. Geller, Toshinori Hayashi, Catherine A. Ray, T. Reh, O. Bermingham-McDonogh, Sherri M. Jones, C. G. Wright, Sami J. Melki, Y. Imanishi, K. Palczewski, K. Alagramam, and J. Flannery. Usher syndrome iiia gene clarin-1 is essential for hair cell function and associated neural activation. Human molecular genetics, 18 15:2748-60, Aug 2009. URL: https://doi.org/10.1093/hmg/ddp210, doi:10.1093/hmg/ddp210. This article has 102 citations and is from a domain leading peer-reviewed journal.
(xu2020clarin‐1expressionin pages 10-14): Lei Xu, Susan N Bolch, Clayton P Santiago, Frank M Dyka, Omar Akil, Ekaterina S Lobanova, Yuchen Wang, Kirill A Martemyanov, William W Hauswirth, W Clay Smith, James T Handa, Seth Blackshaw, John D Ash, and Astra Dinculescu. Clarin‐1 expression in adult mouse and human retina highlights a role of müller glia in usher syndrome. The Journal of Pathology, 250:195-204, Dec 2020. URL: https://doi.org/10.1002/path.5360, doi:10.1002/path.5360. This article has 35 citations.
(dulon2018clarin1genetransfer pages 13-14): Didier Dulon, Samantha Papal, Pranav Patni, Matteo Cortese, Philippe F.Y. Vincent, Margot Tertrais, Alice Emptoz, Abdelaziz Tlili, Yohan Bouleau, Vincent Michel, Sedigheh Delmaghani, Alain Aghaie, Elise Pepermans, Olinda Alegria-Prevot, Omar Akil, Lawrence Lustig, Paul Avan, Saaid Safieddine, Christine Petit, and Aziz El-Amraoui. Clarin-1 gene transfer rescues auditory synaptopathy in model of usher syndrome. Journal of Clinical Investigation, 128:3382–3401, Jul 2018. URL: https://doi.org/10.1172/jci94351, doi:10.1172/jci94351. This article has 155 citations and is from a highest quality peer-reviewed journal.
(dulon2018clarin1genetransfer pages 1-3): Didier Dulon, Samantha Papal, Pranav Patni, Matteo Cortese, Philippe F.Y. Vincent, Margot Tertrais, Alice Emptoz, Abdelaziz Tlili, Yohan Bouleau, Vincent Michel, Sedigheh Delmaghani, Alain Aghaie, Elise Pepermans, Olinda Alegria-Prevot, Omar Akil, Lawrence Lustig, Paul Avan, Saaid Safieddine, Christine Petit, and Aziz El-Amraoui. Clarin-1 gene transfer rescues auditory synaptopathy in model of usher syndrome. Journal of Clinical Investigation, 128:3382–3401, Jul 2018. URL: https://doi.org/10.1172/jci94351, doi:10.1172/jci94351. This article has 155 citations and is from a highest quality peer-reviewed journal.
(dinculescu2021retinalgenetherapy pages 6-9): Astra Dinculescu, Brian A. Link, and David A. Saperstein. Retinal gene therapy for usher syndrome: current developments, challenges, and perspectives. International Ophthalmology Clinics, 61:109-124, Sep 2021. URL: https://doi.org/10.1097/iio.0000000000000378, doi:10.1097/iio.0000000000000378. This article has 21 citations and is from a peer-reviewed journal.
(geng2012themechanosensorystructure pages 11-12): Ruishuang Geng, Sami J. Melki, D. Chen, Guilian Tian, D. Furness, Tomoko Oshima-Takago, Jakob Neef, T. Moser, Charles Askew, Geoffrey C. Horwitz, J. R. Holt, Y. Imanishi, and K. Alagramam. The mechanosensory structure of the hair cell requires clarin-1, a protein encoded by usher syndrome iii causative gene. The Journal of Neuroscience, 32:9485-9498, Jul 2012. URL: https://doi.org/10.1523/jneurosci.0311-12.2012, doi:10.1523/jneurosci.0311-12.2012. This article has 76 citations.
(dulon2018clarin1genetransfer pages 7-10): Didier Dulon, Samantha Papal, Pranav Patni, Matteo Cortese, Philippe F.Y. Vincent, Margot Tertrais, Alice Emptoz, Abdelaziz Tlili, Yohan Bouleau, Vincent Michel, Sedigheh Delmaghani, Alain Aghaie, Elise Pepermans, Olinda Alegria-Prevot, Omar Akil, Lawrence Lustig, Paul Avan, Saaid Safieddine, Christine Petit, and Aziz El-Amraoui. Clarin-1 gene transfer rescues auditory synaptopathy in model of usher syndrome. Journal of Clinical Investigation, 128:3382–3401, Jul 2018. URL: https://doi.org/10.1172/jci94351, doi:10.1172/jci94351. This article has 155 citations and is from a highest quality peer-reviewed journal.
(dulon2018clarin1genetransfer pages 14-17): Didier Dulon, Samantha Papal, Pranav Patni, Matteo Cortese, Philippe F.Y. Vincent, Margot Tertrais, Alice Emptoz, Abdelaziz Tlili, Yohan Bouleau, Vincent Michel, Sedigheh Delmaghani, Alain Aghaie, Elise Pepermans, Olinda Alegria-Prevot, Omar Akil, Lawrence Lustig, Paul Avan, Saaid Safieddine, Christine Petit, and Aziz El-Amraoui. Clarin-1 gene transfer rescues auditory synaptopathy in model of usher syndrome. Journal of Clinical Investigation, 128:3382–3401, Jul 2018. URL: https://doi.org/10.1172/jci94351, doi:10.1172/jci94351. This article has 155 citations and is from a highest quality peer-reviewed journal.
(dulon2018clarin1genetransfer pages 17-18): Didier Dulon, Samantha Papal, Pranav Patni, Matteo Cortese, Philippe F.Y. Vincent, Margot Tertrais, Alice Emptoz, Abdelaziz Tlili, Yohan Bouleau, Vincent Michel, Sedigheh Delmaghani, Alain Aghaie, Elise Pepermans, Olinda Alegria-Prevot, Omar Akil, Lawrence Lustig, Paul Avan, Saaid Safieddine, Christine Petit, and Aziz El-Amraoui. Clarin-1 gene transfer rescues auditory synaptopathy in model of usher syndrome. Journal of Clinical Investigation, 128:3382–3401, Jul 2018. URL: https://doi.org/10.1172/jci94351, doi:10.1172/jci94351. This article has 155 citations and is from a highest quality peer-reviewed journal.
(xu2020clarin‐1expressionin pages 22-30): Lei Xu, Susan N Bolch, Clayton P Santiago, Frank M Dyka, Omar Akil, Ekaterina S Lobanova, Yuchen Wang, Kirill A Martemyanov, William W Hauswirth, W Clay Smith, James T Handa, Seth Blackshaw, John D Ash, and Astra Dinculescu. Clarin‐1 expression in adult mouse and human retina highlights a role of müller glia in usher syndrome. The Journal of Pathology, 250:195-204, Dec 2020. URL: https://doi.org/10.1002/path.5360, doi:10.1002/path.5360. This article has 35 citations.
(nonarath2025theush3acausative pages 2-4): Hannah J. T. Nonarath, Samantha L. Simpson, Tricia L. Slobodianuk, Ross F. Collery, Astra Dinculescu, and Brian A. Link. The ush3a causative gene clarin1 functions in müller glia to maintain retinal photoreceptors. PLOS Genetics, Mar 2025. URL: https://doi.org/10.1371/journal.pgen.1011205, doi:10.1371/journal.pgen.1011205. This article has 11 citations and is from a domain leading peer-reviewed journal.
(gopal2019unconventionalsecretorypathway pages 7-8): Suhasini R. Gopal, Yvonne T. Lee, Ruben Stepanyan, Brian M. McDermott, and Kumar N. Alagramam. Unconventional secretory pathway activation restores hair cell mechanotransduction in an ush3a model. Proceedings of the National Academy of Sciences, 116:11000-11009, May 2019. URL: https://doi.org/10.1073/pnas.1817500116, doi:10.1073/pnas.1817500116. This article has 15 citations and is from a highest quality peer-reviewed journal.
(gopal2019unconventionalsecretorypathway pages 1-2): Suhasini R. Gopal, Yvonne T. Lee, Ruben Stepanyan, Brian M. McDermott, and Kumar N. Alagramam. Unconventional secretory pathway activation restores hair cell mechanotransduction in an ush3a model. Proceedings of the National Academy of Sciences, 116:11000-11009, May 2019. URL: https://doi.org/10.1073/pnas.1817500116, doi:10.1073/pnas.1817500116. This article has 15 citations and is from a highest quality peer-reviewed journal.
(gopal2019unconventionalsecretorypathway pages 3-4): Suhasini R. Gopal, Yvonne T. Lee, Ruben Stepanyan, Brian M. McDermott, and Kumar N. Alagramam. Unconventional secretory pathway activation restores hair cell mechanotransduction in an ush3a model. Proceedings of the National Academy of Sciences, 116:11000-11009, May 2019. URL: https://doi.org/10.1073/pnas.1817500116, doi:10.1073/pnas.1817500116. This article has 15 citations and is from a highest quality peer-reviewed journal.
(gopal2019unconventionalsecretorypathway pages 4-5): Suhasini R. Gopal, Yvonne T. Lee, Ruben Stepanyan, Brian M. McDermott, and Kumar N. Alagramam. Unconventional secretory pathway activation restores hair cell mechanotransduction in an ush3a model. Proceedings of the National Academy of Sciences, 116:11000-11009, May 2019. URL: https://doi.org/10.1073/pnas.1817500116, doi:10.1073/pnas.1817500116. This article has 15 citations and is from a highest quality peer-reviewed journal.
(wang2024araretranscript pages 9-11): Suyang Wang, Chen Yang Xu, Yiming Zhu, Wenjuan Ding, Jieyu Hu, Baicheng Xu, Yufen Guo, and Xiaowen Liu. A rare transcript homozygous variants in clrn1(ush3a) causes usher syndrome type 3 in a chinese family. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03348-x, doi:10.1186/s13023-024-03348-x. This article has 2 citations and is from a peer-reviewed journal.
(wang2024araretranscript pages 2-4): Suyang Wang, Chen Yang Xu, Yiming Zhu, Wenjuan Ding, Jieyu Hu, Baicheng Xu, Yufen Guo, and Xiaowen Liu. A rare transcript homozygous variants in clrn1(ush3a) causes usher syndrome type 3 in a chinese family. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03348-x, doi:10.1186/s13023-024-03348-x. This article has 2 citations and is from a peer-reviewed journal.
(wang2024araretranscript pages 11-12): Suyang Wang, Chen Yang Xu, Yiming Zhu, Wenjuan Ding, Jieyu Hu, Baicheng Xu, Yufen Guo, and Xiaowen Liu. A rare transcript homozygous variants in clrn1(ush3a) causes usher syndrome type 3 in a chinese family. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03348-x, doi:10.1186/s13023-024-03348-x. This article has 2 citations and is from a peer-reviewed journal.
(dulon2018clarin1genetransfer pages 10-13): Didier Dulon, Samantha Papal, Pranav Patni, Matteo Cortese, Philippe F.Y. Vincent, Margot Tertrais, Alice Emptoz, Abdelaziz Tlili, Yohan Bouleau, Vincent Michel, Sedigheh Delmaghani, Alain Aghaie, Elise Pepermans, Olinda Alegria-Prevot, Omar Akil, Lawrence Lustig, Paul Avan, Saaid Safieddine, Christine Petit, and Aziz El-Amraoui. Clarin-1 gene transfer rescues auditory synaptopathy in model of usher syndrome. Journal of Clinical Investigation, 128:3382–3401, Jul 2018. URL: https://doi.org/10.1172/jci94351, doi:10.1172/jci94351. This article has 155 citations and is from a highest quality peer-reviewed journal.
(dinculescu2016aavmediatedclarin1expression pages 1-2): Astra Dinculescu, Rachel M. Stupay, Wen-Tao Deng, Frank M. Dyka, Seok-Hong Min, Sanford L. Boye, Vince A. Chiodo, Carolina E. Abrahan, Ping Zhu, Qiuhong Li, Enrica Strettoi, Elena Novelli, Kerstin Nagel-Wolfrum, Uwe Wolfrum, W. Clay Smith, and William W. Hauswirth. Aav-mediated clarin-1 expression in the mouse retina: implications for ush3a gene therapy. PLoS ONE, 11:e0148874, Feb 2016. URL: https://doi.org/10.1371/journal.pone.0148874, doi:10.1371/journal.pone.0148874. This article has 23 citations and is from a peer-reviewed journal.